Literature DB >> 16181980

The past, present and future of plasmin inhibitor.

Nobuo Aoki1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16181980     DOI： 10.1016/j.thromres.2004.12.019

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  6 in total

Review 1.  α2-Antiplasmin: New Insights and Opportunities for Ischemic Stroke.

Authors:  Guy L Reed; Aiilyan K Houng; Satish Singh; Dong Wang
Journal:  Semin Thromb Hemost       Date:  2016-07-29       Impact factor: 4.180

2.  Noncovalent interaction of alpha(2)-antiplasmin with fibrin(ogen): localization of alpha(2)-antiplasmin-binding sites.

Authors:  Galina Tsurupa; Sergiy Yakovlev; Patrick McKee; Leonid Medved
Journal:  Biochemistry       Date:  2010-09-07       Impact factor: 3.162

Review 3.  Natural and synthetic inhibitors of kallikrein-related peptidases (KLKs).

Authors:  Peter Goettig; Viktor Magdolen; Hans Brandstetter
Journal:  Biochimie       Date:  2010-07-06       Impact factor: 4.079

4.  Incorporation of albumin fusion proteins into fibrin clots in vitro and in vivo: comparison of different fusion motifs recognized by factor XIIIa.

Authors:  William P Sheffield; Louise J Eltringham-Smith
Journal:  BMC Biotechnol       Date:  2011-12-20       Impact factor: 2.563

5.  Addition of a sequence from alpha2-antiplasmin transforms human serum albumin into a blood clot component that speeds clot lysis.

Authors:  William P Sheffield; Louise J Eltringham-Smith; Sharon Gataiance; Varsha Bhakta
Journal:  BMC Biotechnol       Date:  2009-03-03       Impact factor: 2.563

6.  Identification of serum biomarkers in dogs naturally infected with Babesia canis canis using a proteomic approach.

Authors:  Josipa Kuleš; Vladimir Mrljak; Renata Barić Rafaj; Jelena Selanec; Richard Burchmore; Peter D Eckersall
Journal:  BMC Vet Res       Date:  2014-05-12       Impact factor: 2.741
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.